Zai Lab (ZLAB) EPS (Weighted Average and Diluted) (2021 - 2026)
Zai Lab's (ZLAB) quarterly EPS (Weighted Average and Diluted) came in at -$0.05 in Q1 2026, down 25.0% year-on-year from -$0.07 in Q1 2025, and little changed quarter-over-quarter from -$0.05 in Q4 2025.
Zai Lab (ZLAB) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Zai Lab has disclosed EPS (Weighted Average and Diluted) across 6 years of filings, most recently posting -$0.05 for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.05, down 25.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.17 (up 29.17% YoY), and the FY2025 annual result was -$0.16, up 38.46% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.05 for Q1 2026 at Zai Lab, roughly flat from -$0.05 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.03 in Q3 2025 to a low of -$0.17 in Q3 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.06 (2022), against an average of -$0.07.
- Peak annual rise in EPS (Weighted Average and Diluted) reached 73.91% in 2022, while the deepest fall reached 70.0% in 2022.
- Zai Lab's EPS (Weighted Average and Diluted) stood at -$0.06 in 2022, then plunged by 66.67% to -$0.1 in 2023, then climbed by 20.0% to -$0.08 in 2024, then soared by 37.5% to -$0.05 in 2025, then changed by 0.0% to -$0.05 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.05 (Q1 2026), -$0.05 (Q4 2025), and -$0.03 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | -0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.05 |
| Dec 31, 2025 | -0.05 |
| Sep 30, 2025 | -0.03 |
| Jun 30, 2025 | -0.04 |
| Mar 31, 2025 | -0.04 |
| Dec 31, 2024 | -0.08 |
| Sep 30, 2024 | -0.04 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | -0.05 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -0.07 |
| Jun 30, 2023 | -0.13 |
| Mar 31, 2023 | -0.05 |
| Dec 31, 2022 | -0.06 |
| Sep 30, 2022 | -0.17 |
| Jun 30, 2022 | -0.14 |
| Mar 31, 2022 | -0.09 |
| Dec 31, 2021 | -0.23 |
| Sep 30, 2021 | -0.10 |
| Jun 30, 2021 | -0.18 |